Immuron Limited reports a striking 70% quarter-on-quarter increase in Travelan® sales, driven by expanded pharmacy distribution in Australia and North America.
Spacetalk Limited reports a robust 12% increase in Annual Recurring Revenue to $11 million, driven by a 21% jump in paid mobile subscribers, signaling strong momentum and international ambitions.